Works matching DE "EPIDERMAL growth factor receptors"

Results: 5000

阿美替尼对比奥希替尼治疗 EGFR突变晚期 NSCLC 的临床疗效研究.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2025, v. 46, n. 5, p. 89, doi. 10.12259/j.issn.2095-610X.S20250510

By:

杨升锡;
朱加德;
李秋睿;
屠文莲

Publication type:

Article

Evaluating the Efficacy and Safety of Kinesiology Tape Wrapping as Adjunct Therapy for Epidermal Growth Factor Receptor–Induced Paronychia.

Published in:

Dermatologic Therapy, 2025, v. 2025, p. 1, doi. 10.1155/dth/7019466

By:

Wang, Ying-Hsiang;
Lin, Shang-Hung;
Cheng, Yu-Wen;
Yang, Yi-Chien;
Hsu, Ting-Jung;
Saleem, Suraiya

Publication type:

Article

Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival.

Published in:

Journal of Neuro-Oncology, 2025, v. 174, n. 1, p. 157, doi. 10.1007/s11060-025-05048-3

By:

Michel, Anna;
Rauschenbach, Laurèl;
Karadachi, Hanah;
Gümüs, Meltem;
Ahmadipour, Yahya;
Darkwah Oppong, Marvin;
Pöttgen, Christoph;
Hense, Jörg;
Özkan, Neriman;
Wrede, Karsten H.;
Dammann, Philipp;
Sure, Ulrich;
Jabbarli, Ramazan

Publication type:

Article

Survival outcomes of HER2 low patients with metastatic breast cancer: a retrospective analysis.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 6, p. 127, doi. 10.22514/ejgo.2025.087

By:

Dogan, Ozlem;
Sahinli, Hayriye;
Cilbir, Ebru;
Duzkopru, Yakup

Publication type:

Article

PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitors.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 7, p. 1341, doi. 10.1007/s10147-025-02770-w

By:

Önder, Tuğba;
Öner, İrem;
Karaçin, Cengiz;
Ateş, Öztürk

Publication type:

Article

Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 7, p. 1331, doi. 10.1007/s10147-025-02768-4

By:

Togashi, Yusa;
Nagahashi, Masayuki;
Oshiro, Aoi;
Sugimoto, Gen;
Mitsuyoshi, Ayumu;
Kanaoka, Haruka;
Hattori, Akira;
Tsuchida, Junko;
Higuchi, Tomoko;
Nishimukai, Arisa;
Miyoshi, Yasuo

Publication type:

Article

FDA Grants Accelerated Approval to Datopotamab Deruxtecan-Dlnk for EGFR-Positive Non-Small Cell Lung Cancer.

Published in:: ONS Voice, 2025, p. N.PAG
Publication type:: Article

接受抗 PD-1 免疫治疗的胃癌腹膜转移患者疗效的生物标志物探索.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 6, p. 525, doi. 10.3760/cma.j.cn112152-20240826-00368

By:

魏禹焘;
汪越;
杨菊;
王寒冰;
周啸宇;
潘云枫;
任世纪;
刘文琪;
刘宝瑞;
魏嘉

Publication type:

Article

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis.

Published in:

European Journal of Medical Research, 2025, v. 30, n. 1, p. 1, doi. 10.1186/s40001-025-02806-x

By:

Danbala, Isah Adamu;
Wang, Xu;
Su, Yuting;
Tang, Haowen;
Sheng, Wanying;
Shaibu, Zakari;
Isah, Iliyasu;
Yuan, Xiao

Publication type:

Article

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial.

Published in:

NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00777-0

By:

Albanell, Joan;
Pozo, Angelo Gámez;
Arteaga, Carlos L.;
Bellet, Meritxell;
Rojo, Federico;
González, Abel;
Bellosillo, Beatriz;
Serra, Violeta;
Gener, Petra;
Guerrero, José Antonio;
Shimizu, Eileen;
Mancino, Mario;
Rodríguez-Morató, Jose;
Mina, Leonardo;
Pérez-García, José Manuel;
Cortés, Javier;
Llombart-Cussac, Antonio

Publication type:

Article

HER2 and hormone receptor conversion after neoadjuvant therapy for breast cancer.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1522460

By:

Wang, Jing;
Long, Xin;
Tang, Mingxi;
Xiao, Xiuli

Publication type:

Article

Substituted 1,3,4‐oxadiazole coupled 1,2,3‐triazole derivatives as antiproliferative agents: Design, synthesis, biological evaluation and in silico studies.

Published in:

Journal of the Chinese Chemical Society, 2025, v. 72, n. 6, p. 721, doi. 10.1002/jccs.70025

By:

Gandamalla, Sreenivas;
Mavurapu, Satyanarayana;
Sambaru, Kalyani;
Allaka, Tejeswara Rao

Publication type:

Article

Bilateral Primary Breast Cancer With Discordance in Molecular Subtypes: A Case Report.

Published in:

International Journal of Breast Cancer, 2025, v. 2025, p. 1, doi. 10.1155/ijbc/9082803

By:

Rao, Yingying;
Zhan, Qian;
Li, Hengyu;
Ribeiro, Ivana

Publication type:

Article

Editorial for "The Potential of Model‐Free Parameters Derived From IVIM in Evaluating Pathological Indicators and Long‐Term Survival in NPC".

Published in:

2025

By:

Sollmann, Nico

Publication type:

Editorial

The Potential of Model‐Free Parameters Derived From IVIM in Evaluating Pathological Indicators and Long‐Term Survival in NPC.

Published in:

Journal of Magnetic Resonance Imaging, 2025, v. 62, n. 1, p. 73, doi. 10.1002/jmri.29725

By:

Yang, Fan;
Wei, Haoran;
Li, Xiaolu;
Yu, Xiaoduo;
Li, Lin;
Zhao, Yanfeng;
Xie, Lizhi;
Jiang, Yueluan;
Lin, Meng;
Zhang, Hongmei

Publication type:

Article

Editorial for "Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRI".

Published in:

2025

By:

Morrell, Glen R.

Publication type:

Editorial

Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRI.

Published in:

Journal of Magnetic Resonance Imaging, 2025, v. 61, n. 5, p. 2212, doi. 10.1002/jmri.29670

By:

Dai, Yi;
Lian, Chun;
Zhang, Zhuo;
Gao, Jing;
Lin, Fan;
Li, Ziyin;
Wang, Qi;
Chu, Tongpeng;
Aishanjiang, Dilinuer;
Chen, Meiying;
Wang, Ximing;
Cheng, Guanxun;
Huang, Rong;
Dong, Jianjun;
Zhang, Haicheng;
Mao, Ning

Publication type:

Article

Kapsaisin'in duodenumda histomorfolojik değişiklikler, IGF-I, EGFR ifadeleri ve hücre proliferasyonu üzerine etkisinin incelenmesi.

Published in:

Dicle Medical Journal / Dicle Tip Dergisi, 2025, v. 52, n. 1, p. 145, doi. 10.5798/dicletip.1657567

By:

Asmaz, Ender Deniz;
Zık, Berrin

Publication type:

Article

HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells.

Published in:

OncoImmunology, 2014, v. 3, n. 11, p. N.PAG, doi. 10.4161/21624011.2014.956012

By:

Miller, Megan Jo;
Foy, Kevin C.;
Overholser, Jay P.;
Nahta, Rita;
Kaumaya, Pravin T. P.

Publication type:

Article

IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.

Published in:

OncoImmunology, 2014, v. 3, n. 11, p. N.PAG, doi. 10.4161/21624011.2014.956005

By:

Foy, Kevin Chu;
Miller, Megan J.;
Overholser, Jay;
Donnelly, Siobhan M.;
Nahta, Rita;
Kaumaya, Pravin T. P.

Publication type:

Article

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24677-1, doi. 10.4161/onci.24677

By:

Chwee Ming Lim;
Stephenson, Ryan;
Salazar, Andres M.;
Ferris, Robert L.

Publication type:

Article

Contribution of 18Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.

Published in:

Cancer Biomarkers, 2016, v. 16, n. 3, p. 489, doi. 10.3233/CBM-160588

By:

Kanmaz, Zehra Dilek;
Aras, Gülfidan;
Tuncay, Esin;
Bahadır, Ayşe;
Kocatürk, Celalettin;
Yaşar, Zehra Asuk;
Öz, Büge;
Özkurt, Canan Ünlü;
Gündoğan, Cihan;
Çermik, Tevfik Fikret

Publication type:

Article

Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer.

Published in:

Cancer Biomarkers, 2016, v. 16, n. 3, p. 425, doi. 10.3233/CBM-160581

By:

Sehhoon Park;
Seongyeol Park;
Se-Hoon Lee;
Beomseok Suh;
Chan-Young Ock;
Bhumsuk Keam;
TaeMin Kim;
Dong-Wan Kim;
Young Whan Kim;
Dae Seog Heo

Publication type:

Article

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma.

Published in:

Cancer Biomarkers, 2016, v. 16, n. 1, p. 19, doi. 10.3233/CBM-150537

By:

Yung-Hung Luo;
Pei-Chun Tseng;
Yu-Chin Lee;
Reury-Perng Perng;
Jacqueline Whang-Peng;
Yuh-Min Chen

Publication type:

Article

Quantification of concentration and assessment of EGFR mutation in circulating DNA.

Published in:

Cancer Biomarkers, 2015, v. 15, n. 4, p. 515, doi. 10.3233/CBM-150471

By:

Mazurek, Agnieszka;
Pierzyna, Magdalena;
Giglok, Monika;
Dworzecka, Urszula;
Suwiński, Rafał;
Małusecka, Ewa

Publication type:

Article

Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: A meta-analysis.

Published in:

Cancer Biomarkers, 2014, v. 14, n. 4, p. 267, doi. 10.3233/CBM-140401

By:

Ma, Xuelei;
Huang, Jingwen;
Wu, Xin;
Li, Xie;
Zhang, Jing;
Xue, Luqi;
Li, Ping;
Liu, Lei

Publication type:

Article

Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer.

Published in:

Cancer Biomarkers, 2013, v. 13, n. 5, p. 329, doi. 10.3233/CBM-130362

By:

Ju, Lixia;
Zhou, Caicun

Publication type:

Article

Biomarker discordance: Prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.

Published in:

Cancer Biomarkers, 2013, v. 12, n. 6, p. 231, doi. 10.3233/CBM-130314

By:

Moussa, Osama;
Purdie, Colin;
Vinnicombe, Sarah;
Thompson, Alastair M.

Publication type:

Article

Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.

Published in:

Cancer Biomarkers, 2012, v. 11, n. 5, p. 219, doi. 10.3233/CBM-2012-00282

By:

Lu, Yuanming;
Jingyan, Gao;
Baorong, Song;
Peng, Junjie;
Xu, Ye;
Cai, Sanjun

Publication type:

Article

Association of early initiation of dialysis with all‐cause and cardiovascular mortality: A propensity score weighted analysis of the United States Renal Data System.

Published in:

Hemodialysis International, 2021, v. 25, n. 2, p. 188, doi. 10.1111/hdi.12912

By:

Bozorgmehri, Shahab;
Aboud, Hussain;
Chamarthi, Gajapathiraju;
Liu, I‐Chia;
Tezcan, Ozrazgat‐Baslanti;
Shukla, Ashutosh M.;
Kazory, Amir;
Rupam, Ruchi;
Segal, Mark S.;
Bihorac, Azra;
Mohandas, Rajesh

Publication type:

Article

Relationship between intrinsic subtypes and tumor responses to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Published in:

Breast Disease, 2012, v. 34, n. 1, p. 9, doi. 10.3233/BD-130345

By:

Ooe, Asako;
Takahara, Sachiko;
Sumiyoshi, Kazuhiro;
Yamamoto, Hitoshi;
Kawai, Jun;
Shiba, Eiichi

Publication type:

Article

Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.

Published in:

Breast Disease, 2021, v. 40, n. 4, p. 241, doi. 10.3233/BD-201076

By:

Ewida, Heba A.;
Shabayek, Marwa;
Seleem, Mae

Publication type:

Article

Urokinase type plasminogen activator receptor (uPAR) and human epidermal growth factor receptor 2 (HER2) expression in metastasis of breast cancer.

Published in:

Breast Disease, 2021, v. 40, p. S1, doi. 10.3233/BD-219001

By:

Smaradhania, Nilam;
Rahman, Septiman;
Ardi Syamsu, Salman;
Prihantono, Prihantono

Publication type:

Article

Breast cancer in elderly Korean women: clinicopathological and biological features.

Published in:

Breast Disease, 2020, v. 39, n. 2, p. 71, doi. 10.3233/BD-190422

By:

Kim, Suk Jung;
Park, Young Mi

Publication type:

Article

Role of CD44 in breast cancer.

Published in:

Breast Disease, 2020, v. 39, n. 1, p. 1, doi. 10.3233/BD-190409

By:

Al-Othman, Nihad;
Alhendi, Ala';
Ihbaisha, Manal;
Barahmeh, Myassar;
Alqaraleh, Moath;
Al-Momany, Bayan Z.

Publication type:

Article

Shorting vorasidenib for IDH mutant low-grade glioma.

Published in:

2024

By:

Wong, Eric T

Publication type:

Editorial

Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1573365

By:

Benthami, Hamza;
Zohair, Basma;
Rezouki, Ibtissam;
Naji, Oumayma;
Miyara, Kenza;
Ennachit, Simohamed;
Elkarroumi, Mohamed;
Aschawa, Hind;
Badou, Abdallah

Publication type:

Article

Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers.

Published in:

European Journal of Breast Health, 2025, v. 21, n. 3, p. 1, doi. 10.4274/ejbh.galenos.2025.2025-2-12

By:

Gemci, Öykü Dila;
Altınay, Serdar;
Gültürk, İlkay;
Tural, Deniz;
Karabulut, Mehmet;
Sakız, Damla Nur

Publication type:

Article

Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma Free.

Published in:

American Journal of Clinical Pathology, 2025, v. 163, n. 6, p. 854, doi. 10.1093/ajcp/aqaf010

By:

Hunter, Natasha;
Han, Lisa;
Corbin, Haley;
Konnick, Eric Q;
Gwin, William R;
Vinayak, Shaveta;
Linden, Hannah;
Audeh, William;
Samraj, Lavanya;
Menicucci, Andrea R;
Group, FLEX Investigators;
Soong, T Rinda

Publication type:

Article

HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry.

Published in:

American Journal of Clinical Pathology, 2025, v. 163, n. 6, p. 837, doi. 10.1093/ajcp/aqaf006

By:

Wilcock, Diane;
Sirohi, Deepika;
Coleman, Joshua F;
Adelhardt, Parisa;
Kim, Jong Taek;
Albertson, Daniel;
Affolter, Kajsa;
Beech, Cameron;
Jedrzkiewicz, Jolanta;
Ruano, Ana L;
Cleary, Allison S;
Mahlow, Jonathan;
Balatico, Michael;
Gulbahce, H Evin

Publication type:

Article

Exploring the molecular mechanism of Taohong Siwu decoction in the treatment of non-small-cell lung cancer based on network pharmacology and molecular docking.

Published in:

Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 6, p. 805, doi. 10.1093/jpp/rgae141

By:

Qin, Yuan;
Lian, Jia-Ning;
Chen, Xin;
Huang, Feng-Yu;
Chen, Hai-Wen;
Dong, Tai-Wei;
Jin, Zuo-Lin

Publication type:

Article

Case Report: Osimertinib-induced acute interstitial lung disease.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1608733

By:

Lin, Zhiwu;
Wu, Liang;
Yu, Yang;
Jiang, Jiudong;
Yang, Yanchun;
Xiao, Guibao

Publication type:

Article

Renal microcirculation and mechanisms in diabetic kidney disease.

Published in:

Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1580608

By:

Hang, Xing;
Ma, Jiang;
Wei, Yu;
Wang, Yayun;
Zang, Xiaoyu;
Xie, Pengfei;
Zhang, Lili;
Zhao, Linhua

Publication type:

Article

It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

Published in:

EJNMMI Radiopharmacy & Chemistry, 2025, v. 10, n. 1, p. 1, doi. 10.1186/s41181-025-00354-7

By:

Trommer, Johanna;
Ullrich, Martin;
Reissig, Falco;
Brühlmann, Santiago Andres;
Nitt-Weber, Anne-Kathrin;
Novy, Zbynek;
Hajduova, Katarina;
Kurfurstova, Daniela;
Hendrychova, Romana;
Bouchal, Jan;
Petrik, Milos;
Neuber, Christin;
Sihver, Wiebke;
Stadlbauer, Sven;
Pietzsch, Jens;
Kreller, Martin;
Kopka, Klaus;
Mamat, Constantin;
Zarschler, Kristof

Publication type:

Article

Focusing attention on brain metastasis: Hot issues.

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 3, p. 353, doi. 10.1093/nop/npaf025

By:

Rudà, Roberta;
Soffietti, Riccardo

Publication type:

Article

Risk factors for type I leptomeningeal metastasis derived from non-small cell lung cancer and the impact of treatment for brain metastases on its development.

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 3, p. 448, doi. 10.1093/nop/npae118

By:

Iuchi, Toshihiko;
Shingyoji, Masato;
Mizuno, Satoko;
Ashinuma, Hironori;
Hasegawa, Yuzo;
Setoguchi, Taiki;
Hosono, Junji;
Sakaida, Tsukasa

Publication type:

Article

4D-QSAR Analyses for EGFR Inhibitors Based on CDDA-OPS-GA Method.

Published in:

Journal of the Chemical Society of Pakistan, 2025, v. 47, n. 3, p. 204

By:

Cai, Biying;
Zhao, Tiansheng;
Qin, Daogang;
Tu, Guogang

Publication type:

Article

Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1595812

By:

Kong, Lingping;
Peng, Lina;
Yang, Xue;
Ma, Qing;
Zhang, Linlin;
Liu, Xia;
Zhong, Diansheng;
Meng, Fanlu

Publication type:

Article

Efficacy and safety of PI3K inhibitors combined with fulvestrant for HR+/HER2− advanced breast cancer: a systematic review and meta-analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1556978

By:

Li, Xuefeng;
Wang, Hongxian;
Lin, Shuhui;
Chen, Tianwen

Publication type:

Article

Development of Traditional Chinese Medicine in combination with EGFR Inhibitors against Cancer.

Published in:

Journal of Cancer, 2025, v. 16, n. 8, p. 2595, doi. 10.7150/jca.109420

By:

Xiao Chen;
Tiansheng Zheng;
Bingjie Hao;
Shumeng Lin;
Liduo Yue;
Lihong Fan

Publication type:

Article